Pharma aids in Singapore manufacturing growth

Singapore's manufacturing industry expanded in June, the second time in as many months, with a boost from pharma output. The Purchasing Managers' Index, a leading indicator of manufacturing activity, turned positive in May for the first time in nine months, standing at 51.2. The trend continued in June, with a reading of 51.1. A reading above 50 indicates expansion, according to an announcement from Contact Singapore, an alliance of the Singapore Economic Development Board and Ministry of Manpower.

"The biomedical manufacturing sector expanded 120.4 percent year on year in May, thanks to a 138.6 percent leap in pharmaceutical output," the announcement says. A switch to higher-value patented drug compounds following U.S. approvals drove the increase, with help from a low base last May.

Electronics and aerospace manufacturing were also drivers.

- here's the release

Suggested Articles

The FDA has lambasted the Torrent Pharmaceuticals in a warning letter for making OTC meds using water tainted with bacteria.

Eli Lilly is investing $400 million in its Indianapolis site to expand production of insulin and other diabetes meds, and add 100 jobs.

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.